13 | LigandsIBA
03/2024
-
03/2015 |
6 | Histamine H3 Receptors (Histamine H3 Receptor)IBA
12/2022
-
01/2019 |
5 | Amyloid (Amyloid Fibrils)IBA
12/2023
-
06/2015 |
5 | ButyrylcholinesteraseIBA
12/2023
-
12/2015 |
5 | Cholinesterases (Cholinesterase)IBA
12/2022
-
01/2007 |
3 | GABA Plasma Membrane Transport ProteinsIBA
12/2023
-
01/2021 |
3 | EnzymesIBA
06/2021
-
12/2015 |
3 | tau Proteins (tau Protein)IBA
01/2021
-
12/2017 |
3 | AcidsIBA
05/2020
-
01/2017 |
3 | Thymidine PhosphorylaseIBA
01/2019
-
02/2014 |
3 | GlucosidasesIBA
01/2018
-
06/2014 |
2 | Scopolamine (Hyoscine)FDA Link
12/2023
-
06/2021 |
2 | Amyloid Precursor Protein Secretases (beta-Secretase)IBA
12/2023
-
01/2018 |
2 | Analgesics (Analgesic Drugs)IBA
12/2022
-
12/2020 |
2 | Monoamine Oxidase (MAO)IBA
06/2021
-
01/2021 |
2 | Acetylcholine (Acetylcholine Chloride)FDA Link
12/2017
-
03/2014 |
2 | Amyloid beta-PeptidesIBA
01/2017
-
03/2016 |
2 | AcetylcholinesteraseIBA
12/2015
-
01/2007 |
2 | Cholinergic Agents (Cholinergics)IBA
03/2013
-
01/2007 |
1 | 3,5-dichlorobenzoic acidIBA
12/2023 |
1 | Proteins (Proteins, Gene)FDA Link
02/2023 |
1 | Solute Carrier ProteinsIBA
02/2023 |
1 | CreatineIBA
02/2023 |
1 | TaurineFDA Link
02/2023 |
1 | benzophenoneIBA
12/2022 |
1 | Sirolimus (Rapamycin)FDA Link
01/2022 |
1 | Anticonvulsants (Antiepileptic Drugs)IBA
10/2021 |
1 | Formaldehyde (Formol)FDA Link
10/2021 |
1 | purineIBA
07/2021 |
1 | naphthaleneIBA
07/2021 |
1 | ImidazolidinesIBA
07/2021 |
1 | HydantoinsIBA
07/2021 |
1 | diphenyl (biphenyl)IBA
06/2021 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
01/2021 |
1 | Organophosphorus CompoundsIBA
01/2021 |
1 | OximesIBA
01/2021 |
1 | Aminobutyrates (Aminobutyric Acid)IBA
01/2021 |
1 | Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 |
1 | Streptozocin (Streptozotocin)FDA Link
01/2021 |
1 | Dizocilpine Maleate (Dizocilpine)IBA
12/2020 |
1 | Tacrine (Cognex)FDA Link
10/2019 |
1 | RadiopharmaceuticalsIBA
10/2019 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2019 |
1 | Gallium-68IBA
10/2019 |
1 | OSM-LIF ReceptorsIBA
08/2019 |
1 | imidazoleIBA
01/2019 |
1 | Cholinesterase Inhibitors (Anticholinesterases)IBA
02/2018 |
1 | ThioureaIBA
01/2018 |
1 | pyridine sulfonamideIBA
12/2015 |
1 | 2-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA
03/2014 |
1 | OxadiazolesIBA
02/2014 |
1 | Local AnestheticsIBA
11/2012 |
1 | Epinephrine (Adrenaline)FDA LinkGeneric
04/2012 |
1 | 1- (4- (4- (2- methoxyphenyl)piperazin- 1- yl)butyl)- 3- methyl- 5,5- diphenylimidazolidine- 2,4- dione hydrochlorideIBA
04/2012 |
1 | barium chloride (barium dichloride)IBA
04/2012 |
1 | phenylpiperazineIBA
04/2012 |